Melan-A/MART-1 Antibody (MLANA/8365R) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-21039H
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin
Label
HRP
Antibody Source
Recombinant Monoclonal Rabbit IgG Kappa Clone # MLANA/8365R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fragment corresponding to the N-terminus of human Melan-A/MART-1 protein
Localization
Cytoplasm.
Specificity
This monoclonal antibody labels melanomas and other tumors showing melanocytic differentiation It is also a useful positive-marker for angiomyolipomas It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG Kappa
Applications for Melan-A/MART-1 Antibody (MLANA/8365R) [HRP]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Melan-A/MART-1
Alternate Names
Antigen LB39-AA, Antigen SK29-AA, MART-1, MelanA, MLANA
Gene Symbol
MLANA
Additional Melan-A/MART-1 Products
Product Documents for Melan-A/MART-1 Antibody (MLANA/8365R) [HRP]
Product Specific Notices for Melan-A/MART-1 Antibody (MLANA/8365R) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...